Related Experiment Video
Updated: Jun 19, 2026

03:38
Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction
Published on: October 6, 2022
Selectivity of small molecule ligands for parallel and anti-parallel DNA G-quadruplex structures
Thomas P Garner1, Huw E L Williams, Katarzyna I Gluszyk
1Centre for Biomolecular Sciences, School of Chemistry, University Park, Nottingham, NG7 2RD, UK.
Organic & Biomolecular Chemistry
|October 2, 2009
Summary
Ligand binding to DNA quadruplexes shows sequence-specific structural plasticity. Different small molecules exhibit distinct selectivity for parallel and anti-parallel conformations, guiding drug design for cancer targets like telomeres and c-kit.
Area of Science:
- Biochemistry
- Structural Biology
- Medicinal Chemistry
Background:
- DNA quadruplexes, such as those from the human telomeric repeat sequence (h-Tel) and the c-kit promoter, form diverse structures (parallel and anti-parallel).
- Ligand interactions with these structures are crucial for understanding their biological roles and for developing targeted therapies.
Purpose of the Study:
- To investigate the binding interactions of small molecules with different DNA quadruplex structures.
- To determine how ligand architecture influences selectivity for parallel versus anti-parallel quadruplex conformations.
- To assess the structural plasticity of h-Tel and c-kit quadruplexes in response to ligand binding.
Main Methods:
- Circular Dichroism (CD) spectroscopy.
- Electrospray Ionization Mass Spectrometry (ESI-MS).
- Molecular modeling studies.
Main Results:
- The heteroaromatic 1,4-triazole (TRZ) showed some selectivity for parallel h-Tel quadruplexes, while the RHPS4 cation preferred anti-parallel conformations.
- The c-kit parallel quadruplex exhibited limited structural plasticity compared to h-Tel.
- Quantitative ESI-MS revealed ligand binding at both ends of the quadruplexes, with differing affinities for h-Tel and c-kit.
Conclusions:
- Small molecule design can exploit differences in quadruplex structure and plasticity for selective targeting.
- Understanding ligand-induced structural changes is key for developing novel quadruplex-targeting drugs.
- Findings may guide the design of agents targeting telomerase and oncogenic pathways.

